Literature DB >> 35980389

Error in Article Title.

.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35980389      PMCID： PMC9389343          DOI： 10.1001/jamaoncol.2022.3577

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   33.006


× No keyword cloud information.
  1 in total

1.  Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial.

Authors:  Neal D Shore; Joseph Renzulli; Neil E Fleshner; Courtney M P Hollowell; Srinivas Vourganti; Jonathan Silberstein; Rizwan Siddiqui; John Hairston; Dina Elsouda; David Russell; Matthew R Cooperberg; Scott A Tomlins
Journal:  JAMA Oncol       Date:  2022-08-01       Impact factor: 33.006
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.